Indication

Hereditary coproporphyria

Hereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase. Read more about Hereditary coproporphyria

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Hereditary coproporphyria therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Hereditary coproporphyria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hereditary coproporphyria.

Hereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase.

This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the pathologic accumulation and excretion of porphyrin precursors—such as porphobilinogen—and coproporphyrin III.

Clinically, it affects the nervous system and integumentary system, typically presenting with episodic, life-threatening neurovisceral attacks characterized by severe abdominal pain, autonomic dysfunction, motor neuropathies, and psychiatric disturbances, frequently precipitated by porphyrogenic drugs, fasting, or hormonal shifts.

Unlike most other acute porphyrias, a subset of affected individuals also exhibits cutaneous photosensitivity, presenting with skin fragility, erythema, and bullous lesions on sun-exposed areas.

Personalize your experience

Follow Hereditary coproporphyria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it